Items where authors include "Allum, W"

Article

Athauda, A, Nankivell, M, Langley, RE et al. (6 more authors) (2020) Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03). European Journal of Cancer, 137. pp. 45-56. ISSN 0959-8049

Smyth, EC, Rowley, S, Cafferty, FH et al. (17 more authors) (2019) Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial. JAMA Oncology, 5 (8). pp. 1181-1187. ISSN 2374-2437

Lutz, MP, Zalcberg, JR, Ducreux, M et al. (21 more authors) (2019) The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma. European Journal of Cancer, 112. pp. 1-8. ISSN 0959-8049

Mariette, C, Carneiro, F, Grabsch, HI orcid.org/0000-0001-9520-6228 et al. (4 more authors) (2019) Correction to: Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer, 22 (2). p. 421. ISSN 1436-3291

Mariette, C, Carneiro, F, Grabsch, HI et al. (3 more authors) (2019) Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma. Gastric Cancer, 22 (1). pp. 1-9. ISSN 1436-3291

Hewitt, LC, Inam, IZ, Saito, Y et al. (12 more authors) (2018) Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study. European Journal of Cancer, 94. pp. 104-114. ISSN 0959-8049

Smyth, E, Rowley, S, Allum, W et al. (17 more authors) (2016) A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948). Annals of Oncology, 27 (suppl_6). LBA26. ISSN 0923-7534

Obulkasim, A, Yistra, B, Van Essen, HF et al. (11 more authors) (2016) Reduced genomic tumor heterogeneity after neoadjuvat chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma. Oncotarget, 7 (28). pp. 44084-44095. ISSN 1949-2553